CEYRX
Price
$90.12
Change
-$2.53 (-2.73%)
Updated
Apr 3 closing price
Net Assets
6.12B
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

CEYRX vs GFACX

Header iconCEYRX vs GFACX Comparison
Open Charts CEYRX vs GFACXBanner chart's image
Calvert Equity R6
Price$90.12
Change-$2.53 (-2.73%)
VolumeN/A
Net Assets6.12B
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
CEYRX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CEYRX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEYRX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. CEYRX (6.12B). CEYRX pays higher dividends than GFACX: CEYRX (0.39) vs GFACX (0.00). CEYRX was incepted earlier than GFACX: CEYRX (8 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than CEYRX (0.58). GFACX is a more actively managed with annual turnover of: 25.00 vs. CEYRX (9.00). GFACX has a lower initial minimum investment than CEYRX: GFACX (250) vs CEYRX (5000000). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. CEYRX (-2.17). CEYRX return over 5 years is better than : 73.63 vs. GFACX (59.73).
CEYRXGFACXCEYRX / GFACX
Total Expense Ratio0.581.3643%
Annual Report Gross Expense Ratio0.581.3643%
Fund Existence8 years24 years-
Gain YTD0.238-5.003-5%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.12B280B2%
Annual Yield % from dividends0.390.00-
Returns for 1 year-2.17-1.75124%
Returns for 3 years5.720.63905%
Returns for 5 years73.6359.73123%
Returns for 10 yearsN/A44.46-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences